piracetam has been researched along with ticlopidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Al-Bahrani, A; Bakhiet, M; Shaath, H; Taha, S | 1 |
| Hacquard, M; Lacour, JC; Lecompte, T; Richard, S; Vespignani, H | 1 |
3 other study(ies) available for piracetam and ticlopidine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents.
Topics: Acute Disease; Adult; Aged; Aspirin; Brain Ischemia; Cells, Cultured; Clopidogrel; Dipyridamole; Female; Humans; In Vitro Techniques; Interleukin-8; Leukocytes; Male; Middle Aged; Piracetam; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tumor Necrosis Factor-alpha | 2007 |
Levetiracetam-induced platelet dysfunction.
Topics: Aged; Anticonvulsants; Blood Platelet Disorders; Clopidogrel; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Platelet Aggregation; Platelet Aggregation Inhibitors; Seizures; Ticlopidine | 2009 |